1
|
Jermann N, Krusche B, Metag V, Afzal F, Badea M, Beck R, Bielefeldt P, Bieling J, Biroth M, Blanke E, Borisov N, Bornstein M, Brinkmann KT, Ciupka S, Crede V, Dolzhikov A, Drexler P, Dutz H, Elsner D, Fedorov A, Frommberger F, Gardner S, Ghosal D, Goertz S, Gorodnov I, Grüner M, Hammann C, Hartmann J, Hillert W, Hoffmeister P, Honisch C, Jude TC, Kalischewski F, Ketzer B, Klassen P, Klein F, Klempt E, Knaust J, Kolanus N, Kreit J, Krönert P, Lang M, Lazarev AB, Livingston K, Lutterer S, Mahlberg P, Meier C, Meyer W, Mitlasoczki B, Müllers J, Nanova M, Neganov A, Nikonov K, Noël JF, Ostrick M, Ottnad J, Otto B, Penman G, Poller T, Proft D, Reicherz G, Reinartz N, Richter L, Runkel S, Salisbury B, Sarantsev AV, Schaab D, Schmidt C, Schmieden H, Schultes J, Seifen T, Spieker K, Stausberg N, Steinacher M, Taubert F, Thiel A, Thoma U, Thomas A, Urban M, Urff G, Usov Y, van Pee H, Wang YC, Wendel C, Wiedner U, Wunderlich Y. Measurement of polarization observables T, P, and H in π0 and η photoproduction off quasi-free nucleons. Eur Phys J A Hadron Nucl 2023; 59:232. [PMID: 37860634 PMCID: PMC10582157 DOI: 10.1140/epja/s10050-023-01134-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/04/2023] [Accepted: 09/21/2023] [Indexed: 10/21/2023]
Abstract
The target asymmetry T, recoil asymmetry P, and beam-target double polarization observable H were determined in exclusive π 0 and η photoproduction off quasi-free protons and, for the first time, off quasi-free neutrons. The experiment was performed at the electron stretcher accelerator ELSA in Bonn, Germany, with the Crystal Barrel/TAPS detector setup, using a linearly polarized photon beam and a transversely polarized deuterated butanol target. Effects from the Fermi motion of the nucleons within deuterium were removed by a full kinematic reconstruction of the final state invariant mass. A comparison of the data obtained on the proton and on the neutron provides new insight into the isospin structure of the electromagnetic excitation of the nucleon. Earlier measurements of polarization observables in the γ p → π 0 p and γ p → η p reactions are confirmed. The data obtained on the neutron are of particular relevance for clarifying the origin of the narrow structure in the η n system at W = 1.68 GeV . A comparison with recent partial wave analyses favors the interpretation of this structure as arising from interference of the S 11 ( 1535 ) and S 11 ( 1650 ) resonances within the S 11 -partial wave.
Collapse
Affiliation(s)
- N. Jermann
- Department of Physics, University of Basel, Basel, Switzerland
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - B. Krusche
- Department of Physics, University of Basel, Basel, Switzerland
| | - V. Metag
- II. Physikalisches Institut, University of Giessen, Giessen, Germany
| | - F. Afzal
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - M. Badea
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - R. Beck
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - P. Bielefeldt
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - J. Bieling
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - M. Biroth
- Institut für Kernphysik, University of Mainz, Mainz, Germany
| | - E. Blanke
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - N. Borisov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - M. Bornstein
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - K.-T. Brinkmann
- II. Physikalisches Institut, University of Giessen, Giessen, Germany
| | - S. Ciupka
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - V. Crede
- Department of Physics, Florida State University, Tallahassee, USA
| | - A. Dolzhikov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - P. Drexler
- Institut für Kernphysik, University of Mainz, Mainz, Germany
| | - H. Dutz
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - D. Elsner
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - A. Fedorov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - F. Frommberger
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - S. Gardner
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, UK
| | - D. Ghosal
- Department of Physics, University of Basel, Basel, Switzerland
- Present Address: resent address: University of Liverpool, Liverpool, UK
| | - S. Goertz
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - I. Gorodnov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - M. Grüner
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - C. Hammann
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - J. Hartmann
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - W. Hillert
- Physikalisches Institut, University of Bonn, Bonn, Germany
- Present Address: resent address: University of Hamburg, Hamburg, Germany
| | - P. Hoffmeister
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - C. Honisch
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - T. C. Jude
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - F. Kalischewski
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - B. Ketzer
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - P. Klassen
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - F. Klein
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - E. Klempt
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - J. Knaust
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - N. Kolanus
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - J. Kreit
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - P. Krönert
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - M. Lang
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | | | - K. Livingston
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, UK
| | - S. Lutterer
- Department of Physics, University of Basel, Basel, Switzerland
- Present Address: resent address: Ruhr University Bochum, Bochum, Germany
| | - P. Mahlberg
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - C. Meier
- Department of Physics, University of Basel, Basel, Switzerland
| | - W. Meyer
- Institut für Experimentalphysik I, Ruhr University Bochum, Bochum, Germany
| | - B. Mitlasoczki
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - J. Müllers
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - M. Nanova
- II. Physikalisches Institut, University of Giessen, Giessen, Germany
| | - A. Neganov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - K. Nikonov
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - J. F. Noël
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - M. Ostrick
- Institut für Kernphysik, University of Mainz, Mainz, Germany
| | - J. Ottnad
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - B. Otto
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - G. Penman
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, UK
| | - T. Poller
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - D. Proft
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - G. Reicherz
- Institut für Experimentalphysik I, Ruhr University Bochum, Bochum, Germany
| | - N. Reinartz
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - L. Richter
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - S. Runkel
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - B. Salisbury
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - A. V. Sarantsev
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - D. Schaab
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - C. Schmidt
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - H. Schmieden
- Physikalisches Institut, University of Bonn, Bonn, Germany
| | - J. Schultes
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - T. Seifen
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - K. Spieker
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - N. Stausberg
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - M. Steinacher
- Department of Physics, University of Basel, Basel, Switzerland
| | - F. Taubert
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - A. Thiel
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - U. Thoma
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - A. Thomas
- Institut für Kernphysik, University of Mainz, Mainz, Germany
| | - M. Urban
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - G. Urff
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - Y. Usov
- Joint Institute for Nuclear Research, Dubna, Russia
| | - H. van Pee
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - Y. C. Wang
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - C. Wendel
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - U. Wiedner
- Institut für Experimentalphysik I, Ruhr University Bochum, Bochum, Germany
| | - Y. Wunderlich
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
| | - CBELSA/TAPS Collaboration
- Department of Physics, University of Basel, Basel, Switzerland
- Helmholtz-Institut für Strahlen-und Kernphysik, University of Bonn, Bonn, Germany
- II. Physikalisches Institut, University of Giessen, Giessen, Germany
- Institut für Kernphysik, University of Mainz, Mainz, Germany
- Joint Institute for Nuclear Research, Dubna, Russia
- Department of Physics, Florida State University, Tallahassee, USA
- Physikalisches Institut, University of Bonn, Bonn, Germany
- SUPA School of Physics and Astronomy, University of Glasgow, Glasgow, UK
- Institut für Experimentalphysik I, Ruhr University Bochum, Bochum, Germany
- Present Address: resent address: University of Liverpool, Liverpool, UK
- Present Address: resent address: University of Hamburg, Hamburg, Germany
- Present Address: resent address: Ruhr University Bochum, Bochum, Germany
| |
Collapse
|
2
|
Darsaut TE, Findlay JM, Bojanowski MW, Chalaala C, Iancu D, Roy D, Weill A, Boisseau W, Diouf A, Magro E, Kotowski M, Keough MB, Estrade L, Bricout N, Lejeune JP, Chow MMC, O'Kelly CJ, Rempel JL, Ashforth RA, Lesiuk H, Sinclair J, Erdenebold UE, Wong JH, Scholtes F, Martin D, Otto B, Bilocq A, Truffer E, Butcher K, Fox AJ, Arthur AS, Létourneau-Guillon L, Guilbert F, Chagnon M, Zehr J, Farzin B, Gevry G, Raymond J. A Pragmatic Randomized Trial Comparing Surgical Clipping and Endovascular Treatment of Unruptured Intracranial Aneurysms. AJNR Am J Neuroradiol 2023; 44:634-640. [PMID: 37169541 PMCID: PMC10249696 DOI: 10.3174/ajnr.a7865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 04/10/2023] [Indexed: 05/13/2023]
Abstract
BACKGROUND AND PURPOSE Surgical clipping and endovascular treatment are commonly used in patients with unruptured intracranial aneurysms. We compared the safety and efficacy of the 2 treatments in a randomized trial. MATERIALS AND METHODS Clipping or endovascular treatments were randomly allocated to patients with one or more 3- to 25-mm unruptured intracranial aneurysms judged treatable both ways by participating physicians. The study hypothesized that clipping would decrease the incidence of treatment failure from 13% to 4%, a composite primary outcome defined as failure of aneurysm occlusion, intracranial hemorrhage during follow-up, or residual aneurysms at 1 year, as adjudicated by a core lab. Safety outcomes included new neurologic deficits following treatment, hospitalization of >5 days, and overall morbidity and mortality (mRS > 2) at 1 year. There was no blinding. RESULTS Two hundred ninety-one patients were enrolled from 2010 to 2020 in 7 centers. The 1-year primary outcome, ascertainable in 290/291 (99%) patients, was reached in 13/142 (9%; 95% CI, 5%-15%) patients allocated to surgery and in 28/148 (19%; 95% CI, 13%-26%) patients allocated to endovascular treatments (relative risk: 2.07; 95% CI, 1.12-3.83; P = .021). Morbidity and mortality (mRS >2) at 1 year occurred in 3/143 and 3/148 (2%; 95% CI, 1%-6%) patients allocated to surgery and endovascular treatments, respectively. Neurologic deficits (32/143, 22%; 95% CI, 16%-30% versus 19/148, 12%; 95% CI, 8%-19%; relative risk: 1.74; 95% CI, 1.04-2.92; P = .04) and hospitalizations beyond 5 days (69/143, 48%; 95% CI, 40%-56% versus 12/148, 8%; 95% CI, 5%-14%; relative risk: 0.18; 95% CI, 0.11-0.31; P < .001) were more frequent after surgery. CONCLUSIONS Surgical clipping is more effective than endovascular treatment of unruptured intracranial aneurysms in terms of the frequency of the primary outcome of treatment failure. Results were mainly driven by angiographic results at 1 year.
Collapse
Affiliation(s)
- T E Darsaut
- From the Division of Neurosurgery (T.E.D., J.M.F., M.B.K., M.M.C.C., C.J.O.)
| | - J M Findlay
- From the Division of Neurosurgery (T.E.D., J.M.F., M.B.K., M.M.C.C., C.J.O.)
| | | | | | - D Iancu
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - D Roy
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - A Weill
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - W Boisseau
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - A Diouf
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - E Magro
- Service of Neurosurgery (E.M.), Centre Hospitalier Universitaire Cavale Blanche, Institut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 1101 LaTIM, Brest, France
| | - M Kotowski
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - M B Keough
- From the Division of Neurosurgery (T.E.D., J.M.F., M.B.K., M.M.C.C., C.J.O.)
| | - L Estrade
- Interventional Neuroradiology (L.E., N.B.)
| | - N Bricout
- Interventional Neuroradiology (L.E., N.B.)
| | - J-P Lejeune
- Service of Neurosurgery (J.-P.L.), Centre Hospitalier Universitaire de Lille, Lille, France
| | - M M C Chow
- From the Division of Neurosurgery (T.E.D., J.M.F., M.B.K., M.M.C.C., C.J.O.)
| | - C J O'Kelly
- From the Division of Neurosurgery (T.E.D., J.M.F., M.B.K., M.M.C.C., C.J.O.)
| | - J L Rempel
- Department of Surgery, and Department of Radiology and Diagnostic Imaging (J.L.R., R.A.A.), Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta, Canada
| | - R A Ashforth
- Department of Surgery, and Department of Radiology and Diagnostic Imaging (J.L.R., R.A.A.), Mackenzie Health Sciences Centre, University of Alberta Hospital, Edmonton, Alberta, Canada
| | - H Lesiuk
- Section of Neurosurgery (H.L., J.S.)
| | | | - U-E Erdenebold
- Department of Surgery, and Department of Medical Imaging (U.-E.E.), Section of Interventional Neuroradiology, Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
| | - J H Wong
- Division of Neurosurgery (J.H.W.), Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada
| | - F Scholtes
- Departments of Neurosurgery (F.S., D.M.)
| | - D Martin
- Departments of Neurosurgery (F.S., D.M.)
| | - B Otto
- Medical Physics (B.O.), Division of Medical Imaging, Centre Hospitalier Universitaire de Liège, Liège, Belgium
| | - A Bilocq
- Service of Neurosurgery (A.B., E.T.), Centre Hospitalier Régional de Trois-Rivières, Trois-Rivières, Québec, Canada
| | - E Truffer
- Service of Neurosurgery (A.B., E.T.), Centre Hospitalier Régional de Trois-Rivières, Trois-Rivières, Québec, Canada
| | - K Butcher
- Clinical Neurosciences (K.B.), Prince of Wales Clinical School, University of New South Wales, Randwick, New South Wales, Australia
| | - A J Fox
- Department of Medical Imaging (A.J.F.), University of Toronto, Toronto, Ontario, Canada
| | - A S Arthur
- Department of Neurosurgery (A.S.A.), University of Tennessee Health Science Center and Semmes-Murphey Clinic, Memphis, Tennessee
| | - L Létourneau-Guillon
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - F Guilbert
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
| | - M Chagnon
- Department of Mathematics and Statistics (M.C., J.Z.), Université de Montréal, Montréal, Québec, Canada
| | - J Zehr
- Department of Mathematics and Statistics (M.C., J.Z.), Université de Montréal, Montréal, Québec, Canada
| | - B Farzin
- Research Centre of the University of Montreal Hospital Centre (B.F., G.G., J.R.), Interventional Neuroradiology Research Laboratory, Montreal, Québec, Canada
| | - G Gevry
- Research Centre of the University of Montreal Hospital Centre (B.F., G.G., J.R.), Interventional Neuroradiology Research Laboratory, Montreal, Québec, Canada
| | - J Raymond
- Department of Surgery, and Service of Neuroradiology (D.I., D.R., A.W., W.B., A.D., M.K., L.L.-G., F.G., J.R.), Department of Radiology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada
- Research Centre of the University of Montreal Hospital Centre (B.F., G.G., J.R.), Interventional Neuroradiology Research Laboratory, Montreal, Québec, Canada
| |
Collapse
|
3
|
Kietzerow J, Otto B, Wilke N, Rohde H, Iwersen-Bergmann S, Andresen-Streichert H. The challenge of post-mortem GHB analysis: storage conditions and specimen types are both important. Int J Legal Med 2019; 134:205-215. [PMID: 31598775 DOI: 10.1007/s00414-019-02150-w] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Accepted: 08/20/2019] [Indexed: 11/30/2022]
Abstract
BACKGROUND For the interpretation of concentrations of gamma-hydroxybutyrate (GHB) in post-mortem specimens, a possible increase due to post-mortem generation in the body and in vitro has to be considered. The influence of different storage conditions and the specimen type was investigated. METHOD AND MATERIAL Post-mortem GHB concentrations in femoral venous blood (VB), heart blood (HB), serum (S) from VB, urine (U), cerebrospinal fluid (CSF) and vitreous humour (VH) were determined by gas chromatography-mass spectrometry after derivatisation. Various storage conditions, that is 4 °C or room temperature (RT) and the addition of sodium fluoride (NaF), were compared during storage up to 30 days. Additionally, bacterial colonisation was determined by mass spectrometry fingerprinting. RESULTS Twenty-six cases without involvement of exogenous GHB were examined. GHB concentrations (by specimen) at day 0 were 3.9-22.1 mg/L (VB), 6.6-33.3 mg/L (HB), < 0.5-18.1 mg/L (U), 1.1-10.4 mg/L (CSF) and 1.7-22.0 mg/L (VH). At 4 °C, concentrations increased at day 30 to 5.6-74.5 mg/L (VB), 4.6-76.5 mg/L (HB) and < 0.5-21.3 mg/L (U). At RT, concentrations rose to < 0.5-38.5 mg/L (VB), 1.2-94.6 mg/L (HB) and < 0.5-37.5 mg/L (U) at day 30. In CSF, at RT, an increase up to < 0.5-21.2 mg/L was measured, and at 4 °C, a decrease occurred (< 0.5-6.5 mg/L). GHB concentrations in VH remained stable at both temperatures (1.2-20.9 mg/L and < 0.5-26.2 mg/L). The increase of GHB in HB samples with NaF was significantly lower than that without preservation. No correlation was found between the bacterial colonisation and extent of GHB concentration changes. CONCLUSION GHB concentrations can significantly increase in post-mortem HB, VB and U samples, depending on storage time, temperature and inter-individual differences. Results in CSF, VH, S and/or specimens with NaF are less affected.
Collapse
Affiliation(s)
- J Kietzerow
- Institute of Legal Medicine, Department of Forensic Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.,Institute of Legal Medicine, Department of Forensic Toxicology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany
| | - B Otto
- Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - N Wilke
- Institute of Forensic Medicine, University Medical Center Schleswig-Holstein, Lübeck, Germany
| | - H Rohde
- Department of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - S Iwersen-Bergmann
- Institute of Legal Medicine, Department of Forensic Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - H Andresen-Streichert
- Institute of Legal Medicine, Department of Forensic Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. .,Institute of Legal Medicine, Department of Forensic Toxicology, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
| |
Collapse
|
4
|
Martin D, Otto B, Darsaut T, Scholtes F. [The management of unruptured intracranial aneurysms]. Rev Med Liege 2018; 73:338-343. [PMID: 29926576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The rupture of an intracranial aneurysm is a sudden, unpredictable and potentially severe event. The responsible aneurysm has to be excluded from the cerebral circulation to avoid recurrence. More and more commonly, intracranial aneurysms are detected by coincidence. How to react to these fortuitous discoveries is unclear, because the risk of rupture is difficult to estimate. We present our approach to patients facing this situation and the decision-making process.
Collapse
Affiliation(s)
- D Martin
- Service de Neurochirurgie, CHU Sart Tilman, Liège, Belgique
| | - B Otto
- Service d'Imagerie médicale, Département de Physique médicale, CHU Sart Tilman, Liège, Belgique
| | - T Darsaut
- Département de Neurochirurgie, Université d'Alberta, Edmonton, Alberta, Canada
| | - F Scholtes
- Service de Neurochirurgie, Service de Neuroanatomie, CHU Sart Tilman, Liège, Belgique
| |
Collapse
|
5
|
Ryan F, Otto B, Khan A, Johnston V. A cross-sectional study of work-related and lifestyle factors associated with the health of Australian long distance commute and residential miners. European Journal of Physiotherapy 2017. [DOI: 10.1080/21679169.2017.1381324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- F. Ryan
- School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia
| | - B. Otto
- National Mining Company, Brisbane, Australia
| | - A. Khan
- School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia
| | - V. Johnston
- School of Health and Rehabilitation Sciences, The University of Queensland, Brisbane, Australia
| |
Collapse
|
6
|
Cousin F, Jedidi Z, Otto B, Nchimi A. [Not Available]. Rev Med Liege 2016; 71:475-477. [PMID: 28387101] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Affiliation(s)
| | - Z Jedidi
- Service de Neurologie, CHU de Liège, Site du Sart Tilman, Liège, Belgique
| | - B Otto
- Service de Radiodiagnostic, CHU de Liège, Liège, Belgique
| | - A Nchimi
- GIGA Cardiovascular Disease, Ulg, CHU de Liège, Site du Sart Tilman, Liège, Belgique
| |
Collapse
|
7
|
Ciesek S, Proske V, Otto B, Pischke S, Costa R, Lüthgehetmann M, Polywka S, Klempnauer J, Nashan B, Manns MP, von Hahn T, Lohse AW, Wedemeyer H, Mix H, Sterneck M. Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation. Transpl Infect Dis 2016; 18:326-32. [PMID: 26988272 DOI: 10.1111/tid.12524] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2015] [Revised: 01/14/2016] [Accepted: 02/14/2016] [Indexed: 01/08/2023]
Abstract
BACKGROUND Hepatitis C virus (HCV) infection is associated with a particularly poor outcome after liver transplantation. In December 2014, sofosbuvir/ledipasvir (SOF/LDV) fixed-dose combination (FDC) was approved for HCV genotype 1 and 4 in Europe. In orthotopic liver transplantation (OLT) recipients, the interferon-free treatment of HCV re-infection with novel direct-acting antivirals has been demonstrated to be safe and effective in clinical trials, but real-world data are missing. The aim of this study was to investigate the safety and efficacy of SOF/LDV FDC in OLT recipients in the real-life setting. METHODS All consecutive OLT patients started on SOF/LDV FDC for 12 or 24 weeks at the University Medical Center Hamburg-Eppendorf and Medical School Hannover between October 2014 and August 2015 were retrospectively analyzed (n = 30). The primary efficacy endpoint was sustained virological response (SVR), i.e., absence of viremia 12 weeks after end of treatment (SVR 12). Liver function tests, creatinine, blood count, and HCV RNA (by polymerase chain reaction assay) were determined at each visit. RESULTS SVR was achieved in 29/30 patients (96.67%) treated with SOF/LDV ± ribavirin (RBV) for 12 (n = 4) or 24 weeks (n = 25). Twenty-five patients (86.2%) received RBV. However, in 15 of the 25 patients, RBV administration had to be discontinued because of severe anemia (57.7%). One RBV-treated patient died of a myocardial infarction during antiviral therapy; this event was most likely not directly related to SOF/LDV. Aside from RBV-associated anemia, no severe side effects of the antiviral regimen were observed. CONCLUSION Antiviral treatment with SOF/LDV is highly effective, safe, and well tolerated in OLT recipients. The addition of RBV often results in severe anemia, requiring dose reduction or discontinuation.
Collapse
Affiliation(s)
- S Ciesek
- Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.,Integrated Research and Treatment Center - Transplantation (IFB-Tx), Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany
| | - V Proske
- Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - B Otto
- Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.,German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel site, Hamburg, Germany
| | - S Pischke
- Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.,German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel site, Hamburg, Germany
| | - R Costa
- Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany
| | - M Lüthgehetmann
- Institute for Medical Microbiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - S Polywka
- Institute for Medical Microbiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - J Klempnauer
- Integrated Research and Treatment Center - Transplantation (IFB-Tx), Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany.,General-, Visceral- and Transplant Surgery, Medical School Hannover, Hannover, Germany
| | - B Nashan
- Department of Hepatobiliary Surgery and Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - M P Manns
- Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.,Integrated Research and Treatment Center - Transplantation (IFB-Tx), Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany
| | - T von Hahn
- Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany
| | - A W Lohse
- Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - H Wedemeyer
- Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany.,Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - H Mix
- Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.,Integrated Research and Treatment Center - Transplantation (IFB-Tx), Medical School Hannover, Hannover, Germany.,German Center for Infection Research (DZIF), Hannover-Braunschweig site, Hannover, Germany
| | - M Sterneck
- Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.,German Center for Infection Research (DZIF), Hamburg-Lübeck-Borstel site, Hamburg, Germany
| |
Collapse
|
8
|
Urbain V, Meunier P, Otto B. [ABOUT JUVENILE NASOPHARYNGEAL ANGIOFIBROMA]. Rev Med Liege 2015; 70:461-464. [PMID: 26638448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
We report the case of a young man with a juvenile nasopharyngeal angiofibroma. In this paper, we will first remind the clinical signs of this pathology and its radiological appearance (localisation and extensions). Then we will explain how radioembolisation techniques were used to facilitate the surgical intervention. Finally we will discuss the histology of this tumor.
Collapse
|
9
|
Fung EK, Cheal SM, Chalasani S, Fareedy SB, Otto B, Punzalan B, Humm JL, Bander NH, Osborne JR, Larson SM, Zanzonico PB. TU-F-12A-01: Quantitative Non-Linear Compartment Modeling of 89Zr- and 124I- Labeled J591 Monoclonal Antibody Kinetics Using Serial Non-Invasive Positron Emission Tomography Imaging in a Pre-Clinical Human Prostate Cancer Mouse Model. Med Phys 2014. [DOI: 10.1118/1.4889356] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
10
|
Muto J, Fiho L, Kerr E, Jamshidi A, Oyama K, de Lara D, de Souza Daniel G, Otto B, Carrau R, Prevedello D. Comparison Anterior Transpetrosal Approach with Endonasal Endoscopic Approach to the Petrosal Apex Lesion. J Neurol Surg A Cent Eur Neurosurg 2014. [DOI: 10.1055/s-0034-1382195] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
11
|
Rendenbach C, Yorgan TA, Heckt T, Otto B, Baldauf C, Jeschke A, Streichert T, David JP, Amling M, Schinke T. Effects of extracellular phosphate on gene expression in murine osteoblasts. Calcif Tissue Int 2014; 94:474-83. [PMID: 24366459 DOI: 10.1007/s00223-013-9831-6] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2013] [Accepted: 12/01/2013] [Indexed: 02/07/2023]
Abstract
That phosphate homeostasis is tightly linked to skeletal mineralization is probably best underscored by the fact that the phosphaturic hormone FGF23 is primarily expressed by terminally differentiated osteoblasts/osteocytes and that increased circulating FGF23 levels are causative for different types of hypophosphatemic rickets. In contrast, FGF23 inactivation results in hyperphosphatemia, and unexpectedly this phenotype is associated with severe osteomalacia in Fgf23-deficient mice. In this context it is interesting that different cell types have been shown to respond to extracellular phosphate, thereby raising the concept that phosphate can act as a signaling molecule. To identify phosphate-responsive genes in primary murine osteoblasts we performed genome wide expression analysis with cells maintained in medium containing either 1 or 4 mM sodium phosphate for 6 h. As confirmed by qRT-PCR, this analysis revealed that several known osteoblast differentiation markers (Bglap, Ibsp, and Phex) were unaffected by raising extracellular phosphate levels. In contrast, we found that the expression of Enpp1 and Ank, two genes encoding inhibitors of matrix mineralization, was induced by extracellular phosphate, while the expression of Sost and Dkk1, two genes encoding inhibitors of bone formation, was negatively regulated. The ability of osteoblasts to respond to extracellular phosphate was dependent on their differentiation state, and shRNA-dependent repression of the phosphate transporter Slc20a1 in MC3T3-E1 cells partially abolished their molecular response to phosphate. Taken together, our results provide further evidence for a role of extracellular phosphate as a signaling molecule and raise the possibility that severe hyperphosphatemia can negatively affect skeletal mineralization.
Collapse
Affiliation(s)
- C Rendenbach
- Department of Osteology and Biomechanics, University Medical Center Hamburg Eppendorf, 20246, Hamburg, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
Roemmler-Zehrer J, Geigenberger V, Störmann S, Losa M, Crippa V, Otto B, Bidlingmaier M, Dimopoulou C, Stalla GK, Schopohl J. Food intake regulating hormones in adult craniopharyngioma patients. Eur J Endocrinol 2014; 170:627-35. [PMID: 24474740 DOI: 10.1530/eje-13-0832] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
INTRODUCTION Patients with craniopharyngioma (CP) have disturbances of the hypothalamic-pituitary axis and serious comorbidities such as obesity. We hypothesized that the secretion of hormones regulating the nutritional status is altered in adult patients with CP compared with patients with non-functioning pituitary adenoma (NFPA). METHODS WE INCLUDED 40 CP (50% MALES, MEAN AGE: 49.6±14.3 years) and 40 NFPA (72.5% males, mean age: 63.4±9.8 years) patients. We measured glucose, insulin, leptin, total ghrelin, peptide-YY (PYY) and cholecystokinin (CCK) during oral glucose tolerance test (OGTT). Fat mass (FM) was determined by dual X-ray absorptiometry. RESULTS Gender distribution was not significantly different, but CP patients were significantly younger (P<0.001). CP patients had significantly higher BMI and FM than NFPA patients (BMI 32±8 vs 28±4 kg/m(2), P=0.009 and FM 37±9 vs 33±9%, P=0.02). Fasting glucose level (84±12 vs 78±11 mg/dl, P=0.03), leptin (27.9±34.2 vs 11.9±11.6 μg/l, P=0.008) and leptin levels corrected for percentage FM (0.66±0.67 vs 0.32±0.25 μg/l%, P=0.005) were significantly higher in CP than in NFPA patients, whereas ghrelin was significantly lower (131±129 vs 191±119 ng/l, P=0.035). Insulin, PYY and CCK did not differ significantly between groups. After glucose load, leptin decreased significantly in CP patients (P=0.019). In both groups, ghrelin decreased significantly during OGTT (both P<0.001). The percentage decline was significantly smaller for CP. PYY and CCK increased equally after glucose in both groups. CONCLUSION Our patients with CP have more metabolic complications than our patients with NFPA. The levels of leptin and ghrelin at fasting status and after glucose seem to be altered in CP, whereas changes in insulin, PYY and CCK do not seem to be responsible for the metabolic changes in these patients.
Collapse
Affiliation(s)
- J Roemmler-Zehrer
- Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ziemssenstraße 1, 80336 München, Germany
| | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Schoysman L, Tshibanda JF, Otto B, Sprynger M, Nchimi A. [Transcranial color-coded sonography in the management of patients with cervical and intracranial arterial stenosis]. Rev Med Liege 2014; 69:146-150. [PMID: 24830214] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Technological innovations have endowed the development of powerful tools in medical imaging, such as transcranial color-coded sonography. In addition to other imaging techniques, its relevance in cerebrovascular disorders is increasing. This article aims to describe the technique through specification of its current indications in patients with arterial cervical and intracranial stenosis.
Collapse
|
14
|
Barthelemy N, Gennigens C, Scholtes F, Tshibanda L, Otto B, Piret P, Martin D, Jérusalem G, Coucke P. [Multidisciplinary treatment of glioblastoma]. Rev Med Liege 2014; 69 Suppl 1:63-68. [PMID: 24822308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Glioblastoma is a primary brain tumor that occurs most often in elderly patients. Despite improved management, the prognosis of this cancer remains poor. This review describes the multidisciplinary management of the patient with glioblastoma. It includes surgery, radiation therapy and chemotherapy.
Collapse
|
15
|
Salado A, Scholtes F, Otto B, Reuter G, Henroteaux A, Racaru T, Lenelle J, Kaschten B, Dubuisson A, Martin D. Posterior Cerebral Artery Duplication and Palsy of the Right Third Cranial Nerve. World Neurosurg 2013. [DOI: 10.1016/j.wneu.2013.07.070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Arafat AM, Weickert MO, Adamidou A, Otto B, Perschel FH, Spranger J, Möhlig M, Pfeiffer AFH. The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus. J Clin Endocrinol Metab 2013; 98:4133-42. [PMID: 23966238 DOI: 10.1210/jc.2013-1635] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/13/2023]
Abstract
AIMS/HYPOTHESIS The mechanisms underlying glucagon-induced satiety are incompletely understood. The glucagon-induced reduction in total ghrelin exerted at the hypothalamo-pituitary level might be responsible for this effect. Here we investigated glucagon-suppressive effects on circulating total and acyl-ghrelin, both in obesity and in type 1 diabetes mellitus (T1DM), with respect to the role of glucagon in appetite control. We further aimed to identify a possible mechanistic impact of changes in endogenous insulin. METHODS In our prospective, double-blinded, placebo-controlled study, we investigated the endocrine and metabolic responses to intramuscular glucagon administration in 13 patients with T1DM (6 males, 7 females; body mass index [BMI] 24.8 ± 0.95 kg/m(2)), 11 obese participants (OP; 5 males, 6 females; BMI 34.4 ± 1.7 kg/m(2)), and 13 healthy lean participants (LP; 6 males, 7 females; BMI 21.7 ± 0.6 kg/m(2)). RESULTS As compared with placebo, glucagon significantly increased satiety index in T1DM and in LP (P < .001) but failed to induce satiety in OP (P = .152). Total ghrelin significantly decreased after glucagon administration in all study groups (P < .01). Similarly, acyl-ghrelin significantly decreased in LP (P < .01). However, acyl-ghrelin concentrations showed no change in OP (P = .248) and even increased substantially in T1DM (P < .01). Changes in acyl-ghrelin correlated positively with changes in nonesterified fatty acid concentrations in all groups (r = 0.31-0.43; P < .01). CONCLUSIONS/INTERPRETATION Glucagon-induced satiety was preserved in T1DM but not in obesity. This effect was unrelated to changes in total or acylated ghrelin and was independent of endogenous insulin release. In contrast to the insulin-independent glucagon-induced suppression of total ghrelin, glucagon- and/or insulin-induced modification of lipolysis may determine changes in acylated ghrelin.
Collapse
Affiliation(s)
- A M Arafat
- MD, Department of Endocrinology, Diabetes, and Nutrition, Charité-University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
17
|
Delstanche S, Deflandre T, Otto B, Tshibanda L, Simoni P, Moonen G. [Cerebrotendinous xanthomatosis, a rare, severe, but treatable metabolic disorder]. Rev Med Liege 2013; 68:171-176. [PMID: 23755706] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
Cerebrotendinous xanthomatosis (CTX) is a rare and treatable autosomal recessive disease. The diagnosis should be suspected in the presence of a suggestive clinical triad characterized by early-onset cataract, tendinous xanthomata and neurological symptoms and signs, notably cerebellar ataxia, mental retardation and pyramidal syndrome.The diagnosis is confirmed by demonstrating an increased blood level of cholestanol, or/and by molecular genetic analysis.In typical cases, brain MRI shows bilateral hyperintensity of the cerebellar nucleus dentatus together with cerebral atrophy and leukoencephalopathy. The treatment is based on the administration of chenodeoxycholic acid. The aim is to restore the negative feedback on the enzymatic cascade altered by mutation in the gene CYP27 which induces a 27-hydroxylase deficiency
Collapse
|
18
|
Verdin V, Holemans C, Otto B, Van Damme H, Defraigne JO. [Horner's syndrome revealing a spontaneous carotid artery dissection]. Rev Med Liege 2013; 68:11-15. [PMID: 23444822] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
We report a case of spontaneous carotid artery dissection suspected by the appearance of Horner's syndrome. Under medical treatment, the intramural hematoma resolved within 3 months. The patient had an uneventful recovery, without any residual neurologic deficit. Spontaneous arterial dissection is responsible for a hematoma in the arterial wall without significant trauma. The pathogenesis remains unknown. Predisposing factors seem to exist. The clinical presentation is variable mainly due to local compression of adjacent structures which can precede a transient or permanent neurological deficit. The diagnosis is confirmed by Doppler US, CT angiography or magnetic resonance angiography, the best optional investigations. The treatment mainly consists of stroke prevention by anticoagulation versus antiplatelet therapy. The role of surgery and/or endovascular techniques has not yet been confirmed.
Collapse
Affiliation(s)
- V Verdin
- Service de Neuro-Radiologie, CHU de Liège, Belgique
| | | | | | | | | |
Collapse
|
19
|
Otto B, Haag LM, Fischer A, Plickert R, Kühl AA, Göbel UB, Heimesaat MM, Bereswill S. Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis. Eur J Microbiol Immunol (Bp) 2012; 2:210-9. [PMID: 24688768 PMCID: PMC3962757 DOI: 10.1556/eujmi.2.2012.3.7] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2012] [Accepted: 06/27/2012] [Indexed: 11/19/2022] Open
Abstract
Campylobacter jejuni is one of the predominant causes for foodborne bacterial infections worldwide. We investigated whether signaling of C. jejuni-lipoproteins and -lipooligosaccharide via Toll-like-receptor (TLR) -2 and -4, respectively, is inducing intestinal and extra-intestinal immune responses following infection of conventional IL-10(-/-) mice with chronic colitis. At day 3 following oral infection, IL-10(-/-) mice lacking TLR-2 or TLR-4 harbored comparable C. jejuni strain ATCC 43431 loads in their colon. Interestingly, infected TLR-4(-/-) IL-10(-/-) mice displayed less compromized epithelial barrier function as indicated by lower translocation rates of live gut commensals into mesenteric lymphnodes (MLNs), and exhibited less distinct B lymphocyte responses in their colonic mucosa as compared to naїve IL-10(-/-) controls. Furthermore, in extra-intestinal compartments such as MLNs and spleens, abundance of myeloid cells was less distinct whereas relative percentages of activated T helper cells and cytotoxic T cells were higher in spleens and dendritic cells more abundant in MLNs of infected IL-10(-/-) animals lacking TLR-4 as compared to IL-10(-/-) controls. Taken together, in conventionally colonized IL-10(-/-) mice, TLR-4, but not TLR-2, is involved in mediating extra-intestinal pro-inflammatory immune responses following C. jejuni infection. Thus, conventional IL-10(-/-) mice are well suited to further dissect mechanisms underlying Campylobacter infections in vivo.
Collapse
Affiliation(s)
- B. Otto
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| | - L.-M. Haag
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| | - A. Fischer
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| | - R. Plickert
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| | - A. A. Kühl
- Department of Internal Medicine, Rheumatology and Clinical
Immunology / Research Center Immuno-Sciences (RCIS), Charité – University
Medicine BerlinBerlinGermany
| | - U. B. Göbel
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| | - M. M. Heimesaat
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| | - S. Bereswill
- Department of Microbiology and Hygiene, Charité – University
Medicine BerlinBerlinGermany
| |
Collapse
|
20
|
van Boxel OS, ter Linde JJM, Oors J, Otto B, Feinle-Bisset C, Smout AJPM, Siersema PD. Duodenal lipid-induced symptom generation in gastroesophageal reflux disease: role of apolipoprotein A-IV and cholecystokinin. Neurogastroenterol Motil 2012; 24:350-e168. [PMID: 22300015 DOI: 10.1111/j.1365-2982.2012.01880.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
BACKGROUND Duodenal lipid intensifies the perception of esophageal acid perfusion. Recently, we showed that genes implicated in lipid absorption were upregulated in the duodenum of fasting gastro-esophageal reflux disease (GERD) patients. This suggests that chylomicron production and secretion may be enhanced and, consequently, the release of apolipoprotein A-IV (apoA-IV), a chylomicron-derived signaling protein. ApoA-IV may stimulate release of cholecystokinin (CCK), an activator of vagal afferents. This study evaluated putative involvement of abnormal apoA-IV and CCK responses to lipid in GERD. METHODS Ten GERD patients and 10 healthy volunteers (HV) underwent duodenal perfusion with Intralipid 20%, 2 kcal min(-1) , for 60 min. Symptoms were scored, blood samples collected every 15 min during lipid perfusion and 15 min after discontinuation when duodenal biopsies were taken. Plasma and mucosal concentrations of apoA-IV and CCK and transcript levels of 21 genes implicated in lipid absorption, differentially expressed under fasting conditions, were quantified. KEY RESULTS Heartburn (P = 0.003), abdominal discomfort (P = 0.037) and nausea (P = 0.008) only increased significantly during lipid infusion in GERD patients. Following lipid infusion mean mucosal apoA-IV concentration was lower in GERD patients compared with HV (P = 0.023), whereas plasma concentration tended to be elevated (P = 0.068). Mean mucosal CCK concentration was also lower in GERD patients (P = 0.009). Two genes, HIBADH and JTB, were upregulated in GERD patients (P = 0.008 and P = 0.038, respectively). CONCLUSIONS & INFERENCES Our results suggest excessive duodenal lipid-induced release of apoA-IV and CCK in GERD. We postulate that the resulting heightened activation of duodenal vagal afferents may underlie central sensitization, thereby increasing the perception of reflux events.
Collapse
Affiliation(s)
- O S van Boxel
- Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, the Netherlands.
| | | | | | | | | | | | | |
Collapse
|
21
|
Haag LM, Fischer A, Otto B, Grundmann U, Kühl AA, Göbel UB, Bereswill S, Heimesaat MM. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp) 2012; 2:2-11. [PMID: 24611115 DOI: 10.1556/eujmi.2.2012.1.2] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2012] [Accepted: 01/07/2012] [Indexed: 01/20/2023] Open
Abstract
Campylobacter (C.) jejuni is among the leading bacterial agents causing enterocolitis worldwide. Despite the high prevalence of C. jejuni infections and its significant medical and economical consequences, intestinal pathogenesis is poorly understood. This is mainly due to the lack of appropriate animal models. In the age of 3 months, adult mice display strong colonization resistance (CR) against C. jejuni. Previous studies underlined the substantial role of the murine intestinal microbiota in maintaining CR. Due to the fact that the host-specific gut flora establishes after weaning, we investigated CR against C. jejuni in 3-week-old mice and studied intestinal and extra-intestinal immunopathogenesis as well as age dependent differences of the murine colon microbiota. In infant animals infected orally immediately after weaning C. jejuni strain B2 could stably colonize the gastrointestinal tract for more than 100 days. Within six days following infection, infant mice developed acute enterocolitis as indicated by bloody diarrhea, colonic shortening, and increased apoptotic cell numbers in the colon mucosa. Similar to human campylobacteriosis clinical disease manifestations were self-limited and disappeared within two weeks. Interestingly, long-term C. jejuni infection was accompanied by distinct intestinal immune and inflammatory responses as indicated by increased numbers of T- and B-lymphocytes, regulatory T-cells, neutrophils, as well as apoptotic cells in the colon mucosa. Strikingly, C. jejuni infection also induced a pronounced influx of immune cells into extra-intestinal sites such as liver, lung, and kidney. Furthermore, C. jejuni susceptible weaned mice harbored a different microbiota as compared to resistant adult animals. These results support the essential role of the microflora composition in CR against C. jejuni and demonstrate that infant mouse models resemble C. jejuni mediated immunopathogenesis including the characteristic self-limited enterocolitis in human campylobacteriosis. Furthermore, potential clinical and immunological sequelae of chronic C. jejuni carriers in humans can be further elucidated by investigation of long-term infected infant mice. The observed extraintestinal disease manifestations might help to unravel the mechanisms causing complications such as reactive arthritis or Guillain-Barré syndrome.
Collapse
|
22
|
Roemmler J, Gockel A, Otto B, Bidlingmaier M, Schopohl J. Effects on metabolic variables after 12-month treatment with a new once-a-week sustained-release recombinant growth hormone (GH: LB03002) in patients with GH deficiency. Clin Endocrinol (Oxf) 2012; 76:88-95. [PMID: 21682757 DOI: 10.1111/j.1365-2265.2011.04146.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
INTRODUCTION GH substitution in GH deficiency (GHD) must be subcutaneously administered daily. A new sustained-release formulation of GH (LB03002) has been developed, which has to be injected once a week. As a substudy to the phase III study, we performed this prospective study to evaluate the influence of LB03002 on metabolic variables and hormones. METHODS Eleven patients with GHD [four women/seven men, 58 years (29-69 years)] without GH therapy were included in the study. Eight patients were treated with LB03002 for 12 months and three patients received placebo for 6 months followed by LB03002 for 6 months. A 3-h oral glucose tolerance test (OGTT) was performed at study entry and at study end. Additionally, IGF-I, cholesterol, LDL, HDL, triglycerides, leptin, ghrelin, HbA1c and C-peptide were measured. Body composition was evaluated by dual-energy X-ray absorptiometry (DXA), and waist/hip ratio (WHR) and waist/height (WHtR) ratio were measured by tape and scale. RESULTS Multiple of upper limit of normal (xULN) of IGF-I (0·23 (0·09-0·4) vs 0·71 (0·4-1·04), P < 0·01), WHR (0·98 (0·86-1·04) vs 1·01 (0·86-1·05), P < 0·05) and ghrelin levels [119·8 ng/l (67·7-266·6) vs 137 ng/l (67-289·5), P < 0·05] were significantly higher, whereas fat mass (FM) [34·7% (20·4-49·2) vs 32·4% (16·7-48·5), P < 0·05] and leptin [11·2 μg/l (3·3-55·7) vs 7·05 μg/l (2·4-54·3), P < 0·05] were significantly lower at study end. Glucose, insulin, HOMA-IR, ISI, HOMA-β, C-peptide and HbA1c during OGTT were not significantly different before and after GH substitution, neither were BMI, WHtR, bone mineral density and lipid variables. CONCLUSION Substitution with LB03002 showed statistically significant reduction in FM, which reduces leptin levels and increases ghrelin levels but does not seem to influence glucose and lipid metabolism.
Collapse
Affiliation(s)
- J Roemmler
- Department of Internal Medicine (Endocrinology)-Innenstadt, University of Munich, Germany.
| | | | | | | | | |
Collapse
|
23
|
Kurjak M, Fichna J, Harbarth J, Sennefelder A, Allescher HD, Schusdziarra V, Storr M, Otto B. Effect of GABA-ergic mechanisms on synaptosomal NO synthesis and the nitrergic component of NANC relaxation in rat ileum. Neurogastroenterol Motil 2011; 23:e181-90. [PMID: 21414101 DOI: 10.1111/j.1365-2982.2011.01688.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
BACKGROUND γ-Aminobutyric acid (GABA) acts on specific neural receptors [A, B and C(Aρ)] to modulate gastrointestinal function. The precise role of GABA receptor activation in the regulation of presynaptic nitric oxide (NO) synthesis in nerve terminals is unknown. METHODS Rat ileal nerve terminals were isolated by differential centrifugation. Nitric oxide synthesis was analysed using a L-[(3) H]arginine assay. In vitro studies were performed under non-adrenergic non-cholinergic (NANC) conditions on isolated ileal segments. KEY RESULTS γ-Aminobutyric acid inhibited NO synthesis significantly (n = 6, P < 0.05) [(fmol mg(-1) min(-1)) control: 27.7 ± 1.5, 10(-6) mol L(-1): 19.7 ± 1.3; 10(-5) mol L(-1): 17.5 ± 3.0]. This effect was antagonized by the GABA A receptor antagonist bicuculline and the GABA C receptor antagonist (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid (TPMPA), but not by the GABA B receptor antagonist SCH 50911. The GABA A receptor agonist muscimol [(fmol mg(-1) min(-1)) control: 27.6 ± 1.0, 10(-6) mol L(-1): 19.1 ± 1.7, n = 5, P < 0.05] and the GABA C receptor agonist cis-4-aminocrotonic acid (CACA) [(fmol mg(-1) min(-1)) control: 29.5 ± 3.2, 10(-3) mol L(-1): 20.3 ± 2.5, n = 6, P < 0.05], mimicked the GABA-effect, whereas the GABA B agonist baclofen was ineffective. Bicuculline reversed the inhibitory effect of muscimol, TPMPA antagonized the effect of CACA. In functional experiments the GABA A and C receptor agonists reduced the NANC relaxation induced by electrical field stimulation in rat ileum by about 40%. After NOS-inhibition by Nε-nitro-L-arginine methyl ester (L-NAME) the GABA A receptor agonist had no effect, whereas the GABA C receptor agonist still showed a residual response. CONCLUSIONS & INFERENCES γ-Aminobutyric acid inhibits neural NO synthesis in rat ileum by GABA A and GABA C(Aρ) receptor-mediated mechanisms.
Collapse
Affiliation(s)
- M Kurjak
- Endooffice Abdomen, Munich, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Brennan IM, Seimon RV, Luscombe-Marsh ND, Otto B, Horowitz M, Feinle-Bisset C. Effects of acute dietary restriction on gut motor, hormone and energy intake responses to duodenal fat in obese men. Int J Obes (Lond) 2011; 35:448-56. [PMID: 20680017 DOI: 10.1038/ijo.2010.153] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
BACKGROUND Previous patterns of energy intake influence gastrointestinal function and appetite, probably reflecting changes in small-intestinal nutrient-mediated feedback. Obese individuals consume more fat and may be less sensitive to its gastrointestinal and appetite-suppressant effects than lean individuals. OBJECTIVE To evaluate the hypothesis that, in obese individuals, the effects of duodenal fat on gastrointestinal motor and hormone function, and appetite would be enhanced by a short period on a very-low-calorie diet (VLCD). METHODS Eight obese men (body mass index 34±0.6 kg m(-2)) were studied on two occasions, before (V1), and immediately after (V2), a 4-day VLCD. On both occasions, antropyloroduodenal motility, plasma cholecystokinin (CCK), peptide-YY (PYY) and ghrelin concentrations, and appetite perceptions were measured during a 120-min intraduodenal fat infusion (2.86 kcal min(-1)). Immediately afterwards, energy intake was quantified. RESULTS During V2, basal pyloric pressure and the number and amplitude of isolated pyloric pressure waves (PWs) were greater, whereas the number of antral and duodenal PWs was less, compared with V1 (all P<0.05). Moreover, during V2, baseline ghrelin concentration was higher; the stimulation of PYY and suppression of ghrelin by lipid were greater, with no difference in CCK concentration; and hunger and energy intake (kJ; V1: 4378±691, V2: 3634±700) were less (all P<0.05), compared with V1. CONCLUSIONS In obese males, the effects of small-intestinal lipid on gastrointestinal motility and some hormone responses and appetite are enhanced after a 4-day VLCD.
Collapse
Affiliation(s)
- I M Brennan
- University of Adelaide Discipline of Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
| | | | | | | | | | | |
Collapse
|
25
|
Layer P, Andresen V, Pehl C, Allescher H, Bischoff SC, Classen M, Enck P, Frieling T, Haag S, Holtmann G, Karaus M, Kathemann S, Keller J, Kuhlbusch-Zicklam R, Kruis W, Langhorst J, Matthes H, Mönnikes H, Müller-Lissner S, Musial F, Otto B, Rosenberger C, Schemann M, van der Voort I, Dathe K, Preiss JC. [Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]. Z Gastroenterol 2011; 49:237-93. [PMID: 21287438 DOI: 10.1055/s-0029-1245976] [Citation(s) in RCA: 77] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Affiliation(s)
- P Layer
- Für die Konsensusgruppe Reizdarmsyndrom; Konsensuskonferenz 18./ 19.9.2009.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Kalenga M, Collignon N, Andris C, Deprez M, Otto B. [Third cranial nerve palsies in childhood. A case report of sellar germ cell tumor]. Bull Soc Belge Ophtalmol 2011:31-36. [PMID: 22003762] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/31/2023]
Abstract
PURPOSE Third cranial nerve palsies are unfrequent in childhood and adolescence and are most often congenital. The association of sellar germ cell tumor and ophthalmoplegia is considered as being very rare at this age. CASE REPORT A 11-year-old young girl was examined in emergency with a third left cranial nerve partial palsy associated with one- year duration history of hypopituitarism with insipid diabetes and growth retardation. Cerebral IRM revealed a tumor of the pituitary gland. In histopathological examination of pituitary gland biopsies, lesions were compatibles with a sellar germ cell tumor. CONCLUSION Although they are most often of a congenital nature, third cranial nerve palsies in childhood may be secondary to other causes that should be always taken in mind. When they are secondary to a sellar tumor and according to the clinical presentation and the IRM, the histopahological examination of biopsies is mandatory to have a precise diagnosis.
Collapse
Affiliation(s)
- Mbu Kalenga
- Service d'Ophtalmologie, Centre Hospitalier Universitaire de Liège.
| | | | | | | | | |
Collapse
|
27
|
Abstract
INTRODUCTION Pegvisomant (peg) is a GH receptor antagonist. In de novo acromegalic patients with high GH levels, ghrelin and leptin levels are reduced, suggesting a direct GH-mediated effect. The aim of our study was to evaluate whether peg treatment in acromegalic patients may abolish the GH impact on ghrelin and leptin levels. METHODS Ghrelin, leptin and endogenous GH were measured in ten peg-treated acromegalic patients (three females/seven males, 47 years (28-57)), ten patients with active (act) and ten patients with inactive disease (inact) as well as in ten gender-, age- and body mass index (BMI)-matched healthy volunteers (controls). Endogenous GH was measured using a special in-house assay without interference by peg; total ghrelin and leptin were determined using a commercial RIA and an immunofluorometric in-house assay respectively. RESULTS Age and BMI did not differ significantly between groups. Endogenous GH was significantly higher in peg (6.3 μg/l (1.5-41)) and act (9.3 μg/l (1.7-70)) compared with controls (0.1 μg/l (0.1-3.1)) and inact (0.35 μg/l (0.1-2.0), P<0.001). Ghrelin was significantly higher in peg (232 ng/l (96-351)) compared with act (102 ng/l (33-232), P<0.01), whereas ghrelin was not significantly different between the other groups. Leptin was highest in controls (19 μg/l (4-57)) and lowest in act (6 μg/l (2-21)), but this difference did not reach significance. CONCLUSION Treatment with peg seems to disrupt the feedback loop of ghrelin and GH, leading to elevated ghrelin levels. Furthermore, peg therapy appears not to have a strong impact on leptin levels, as acromegalic patients with and without peg treatment showed similar leptin levels.
Collapse
Affiliation(s)
- J Roemmler
- Department of Internal Medicine (Endocrinology) - Innenstadt, LM-University of Munich, Ziemssenstrasse 1, 80336 Munich, Germany.
| | | | | | | | | |
Collapse
|
28
|
Seimon R, Stewart J, Otto B, Keast R, Clifton P, Feinle-Bisset C. Marked differences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men. Appetite 2010. [DOI: 10.1016/j.appet.2010.04.184] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
29
|
Hippler H, Otto B, Schroeder J, Schubert V, Troe J. Diffusion Controlled Atom Recombination and Photolytic Cage Effect of Halogens in Compressed Gases and Liquids. ACTA ACUST UNITED AC 2010. [DOI: 10.1002/bbpc.19850890308] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
30
|
Hippler H, Otto B, Troe J. Collisional Energy Transfer of Vibrationally Highly Excited Molecules. VI. Energy Dependence of 〈Δ E〉 in Azulene. ACTA ACUST UNITED AC 2010. [DOI: 10.1002/bbpc.19890930404] [Citation(s) in RCA: 62] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
31
|
Roemmler J, Kuenkler M, Otto B, Arafat AM, Bidlingmaier M, Schopohl J. Influence of long-term growth hormone replacement on leptin and ghrelin in GH deficiency before and after glucose load. ACTA ACUST UNITED AC 2009; 158:40-6. [PMID: 19596030 DOI: 10.1016/j.regpep.2009.07.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2009] [Revised: 04/11/2009] [Accepted: 07/02/2009] [Indexed: 12/01/2022]
Abstract
INTRODUCTION This cross-sectional study was performed to evaluate the effect of long-term GH substitution on leptin and ghrelin in GH deficiency (GHD). METHODS Leptin and ghrelin were measured after glucose load for 3 h in 52 pat and 10 age- and BMI-matched healthy controls. 22 GHD pat were on GH substitution (GH-Sub) for a median of 10 yr (range 2-27 yr). 30 age- and BMI-matched GHD pat were not substituted for at least 2 yr (non-Sub). RESULTS Basal leptin (8 microg/l (1-130) vs. 16 microg/l (3-89), p<0.05) and AUC of leptin (p<0.05) was significantly lower in GH-Sub compared to non-Sub. In the control group, leptin was higher compared to GH-Sub and similar to non-Sub (19 microg/l (4-57)). Ghrelin (baseline: non-Sub 113 ng/l (61-270), GH-Sub 145 ng/l (83-280), controls 131 ng/l (83-274)) were slightly but not significantly lower for non-Sub. After glucose load, a significant decrease in leptin appeared in both GHD groups, but not in the control group. Ghrelin decreased significantly in all groups. CONCLUSION Lipolytic GH causes lower leptin in GH-Sub. The reason for similar ghrelin might be the compensating effect of acute GH suppression and stimulating low fat mass on ghrelin. Leptin regulation after glucose load is impaired in GHD, whereas ghrelin regulation seems to be not effected.
Collapse
Affiliation(s)
- J Roemmler
- Department of Internal Medicine (Endocrinology)-Innenstadt, University of Munich, Ziemssenstr. 1, 80336 München, Germany.
| | | | | | | | | | | |
Collapse
|
32
|
|
33
|
Enck P, Kaiser C, Felber M, Riepl RL, Klauser A, Klosterhalfen S, Otto B. Circadian variation of rectal sensitivity and gastrointestinal peptides in healthy volunteers. Neurogastroenterol Motil 2009; 21:52-8. [PMID: 18761628 DOI: 10.1111/j.1365-2982.2008.01182.x] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
The aim of our study was to identify diurnal variation of perception of rectal distension and the release of gastroenteropancreatic hormones. In 12 healthy male volunteers (25 years, range 22-32), a rectal balloon distension was performed. Rectal perception thresholds (minimal, urge and pain) and rectal compliance were double-measured with a computer-controlled barostat at seven standardized time points during the day (from 16.00 to 14.00 hours the following day). Blood samples were taken 30 min before and after each rectal distension procedure to determine plasma levels of cholecystokinin (CCK), pancreatic polypeptide (PP) and motilin. Sensory thresholds for urge and pain varied significantly with the time of day, with higher threshold levels in the evening than in the morning hours. Bowel wall compliance showed as well-significant variance at pain threshold and was higher during daytime than in the evening or at night. In contrast to motilin, release of CCK and PP also showed a significant variation depending on daytime. Perception of rectal distension stimuli as well as compliance was independent of intake of food and peptide hormone levels, but CCK and PP levels increased with food, and PP levels decreased with rectal distension. Significant differences in the perception of rectal distension stimuli for urge and pain depending on daytime were found, but the release of gastrointestinal peptides seemed not to be involved. This circadian variation needs to be taken into account in patients and volunteer studies.
Collapse
Affiliation(s)
- P Enck
- Medical Department VI, University Hospital Tübingen, Tübingen, Germany.
| | | | | | | | | | | | | |
Collapse
|
34
|
Iber T, Hecker K, Vagts DA, Roesner JP, Otto B, Steinicke A, Nöldge-Schomburg GFE, Rossaint R. Xenon anesthesia impairs hepatic oxygenation and perfusion in healthy pigs. Minerva Anestesiol 2008; 74:511-519. [PMID: 18854792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
BACKGROUND Over the last 15 years, there has been growing interest in the noble gas xenon as a new inhalational anesthetic. This is due to its favorable pharmacological properties such as short onset and offset, as well as its hemodynamic stability. However, most volatile anesthetics appear to play an important role in the multi-factorial etiology of perioperative liver injury by decreasing liver blood flow with a subsequent reduction of hepatic oxygen supply. However, the effects of the anesthetic gas xenon on hepatic perfusion and oxygenation have not been completely investigated. METHODS Following ethical approval, 18 anesthetized and acutely monitored pigs were randomly assigned to the two following groups: 9 animals received xenon anesthesia in increasing inspiratory concentrations of 0%, 20%, 50%, and 65% in addition to their basic intravenous anesthesia; 9 animals served as a control group. Measurement points for systemic and regional hemodynamic and oxygenation parameters were performed 30 min after changing the xenon concentration. RESULTS Xenon elicited dose-dependent systemic hemodynamic changes such that the mean arterial pressure did not change, while the heart rate and cardiac output decreased by about 30%, thereby indicating an increase in the systemic vascular resistance. Portal venous blood flow decreased, while hepatic arterial blood flow was unchanged. The oxygen supply of the liver was reduced, but not the rate of indocyanine plasma disappearance from the liver. Furthermore, the increase of liver surface pO2 to systemic hyperoxia was absent, and hepatic lactate uptake was reduced. CONCLUSION Xenon, in addition to basic intravenous anesthesia, elicited a decrease in heart rate and cardiac output and an increase in mean arterial pressure. Similar to volatile anesthetics, xenon does reduce portal venous flow and influences hepatic tissue oxygenation. In contrast, hepatic arterial blood flow remains stable in the presence of xenon, and no changes in the hepatic arterial buffer responses were evident. Xenon does affect hepatic perfusion and oxygenation.
Collapse
Affiliation(s)
- T Iber
- Department of Anesthesiology and Intensive Care Medicine, University of Rostock, Rostock, Germany
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Arafat AM, Adamidou A, Otto B, Weickert MO, Perschel FH, Spranger J, Schöfl C, Möhlig M, Pfeiffer AFH. Glucagon suppression of total but not of acylated ghrelin is preserved in obesity; the impact on appetite control. Exp Clin Endocrinol Diabetes 2008. [DOI: 10.1055/s-0028-1096335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
36
|
Affiliation(s)
- B. Otto
- a Academy of Sciences of the GDR, Central Institute of Isotope and Radiation Research
| | - P. Hecht
- a Academy of Sciences of the GDR, Central Institute of Isotope and Radiation Research
| |
Collapse
|
37
|
Roemmler J, Otto B, Steffin B, Bidlingmaier M, Schopohl J. Serum Leptin and Ghrelin Levels in Active and Inactive Acromegalic Patients During an Oral Glucose Tolerance Test. Exp Clin Endocrinol Diabetes 2008; 117:135-41. [DOI: 10.1055/s-2008-1078739] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
38
|
Weickert MO, Möhlig M, Spranger J, Schöfl C, Loeffelholz CV, Riepl RL, Otto B, Pfeiffer AFH. Effects of euglycemic hyperinsulinemia and lipid infusion on circulating cholecystokinin. J Clin Endocrinol Metab 2008; 93:2328-33. [PMID: 18364380 DOI: 10.1210/jc.2007-2787] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
AIMS Functions of the gut hormone cholecystokinin (CCK) include an important role in the regulation of gastric emptying, postprandial glucose homeostasis, and postmeal satiety. Postprandial CCK responses are significantly blunted in type 2 diabetic patients by unknown mechanisms. We hypothesized that hyperinsulinemia and lipid infusion influence circulating levels of biologically active CCK. METHODS Eleven healthy subjects were studied in a cross-over design after 10-h overnight fasts, using euglycemic-hyperinsulinemic clamps for 443 min, with an additional infusion of lipid-heparin (1.25 ml.min(-1)) or saline (1.25 ml.min(-1)) for the last 300 min after constant plasma glucose levels were achieved. RESULTS Euglycemic-hyperinsulinemia resulted in a sustained, up to 5-fold increase of plasma CCK (P < 0.001). When adding lipid infusion instead of saline, CCK concentrations rapidly declined and returned to baseline levels (CCK(300 min) 1.1 +/- 0.2 vs. 3.3 +/- 0.3 pmol/liter, P < 0.001). Partial intraclass correlation showed an independent correlation of plasma CCK with free fatty acids (r(ic) = -0.377, P < 0.001) but not with serum insulin (r(ic) = 0.077, P = 0.32). Whole-body insulin sensitivity decreased in lipid-exposed subjects (M value 7.1 +/- 0.7 vs. 5.6 +/- 0.9 mg.kg.min(-1), P = 0.017) but was not independently correlated with CCK (r(ic) = 0.040, P = 0.61). CONCLUSIONS We report novel findings showing that circulating CCK markedly increased in the euglycemic-hyperinsulinemic state, possibly as a result of near-complete suppression of circulating free fatty acids. Moreover, raising blood lipids even moderately by lipid infusion rapidly and significantly interfered with this effect, suggesting that a negative feedback mechanism of blood lipids on circulating CCK might exist.
Collapse
Affiliation(s)
- M O Weickert
- Department of Endocrinology, Diabetes, and Nutrition, Charité-University-Medicine, Campus Benjamin Franklin, Free University of Berlin, Berlin, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
39
|
Otto C, Berster J, Otto B, Parhofer K. EFFECTS OF TWO WHOLE BLOOD SYSTEMS (DALI AND LIPOSORBER D) FOR LDL APHERESIS ON CARDIOVASCULAR RISK IN SEVERE HYPERCHOLESTEROLAEMIA. ATHEROSCLEROSIS SUPP 2008. [DOI: 10.1016/s1567-5688(08)70832-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
40
|
Weickert MO, Loeffelholz CV, Arafat AM, Schöfl C, Otto B, Spranger J, Möhlig M, Pfeiffer AF. Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans. J Endocrinol Invest 2008; 31:119-24. [PMID: 18362502 DOI: 10.1007/bf03345577] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Ghrelin is a powerful orexigenic gut hormone. Circulating concentrations of total ghrelin are downregulated by food intake in both acute and chronic hyperinsulinemic states. However, in blood des-acylated (des-acyl) ghrelin is the predominant form that has no orexigenic effects in humans. Circulating acyl-ghrelin has been shown to be suppressed post-prandially and by pharmacological hyperinsulinemia. However, up to now responses of circulating acyl-ghrelin to moderate hyperinsulinemic and hyperinsulinemic-hyperlipidemic clamp conditions have not been reported. Fourteen healthy subjects were investigated using two-stepped euglycemic-hyperinsulinemic clamps (40 mU insulin/ m2/min; mean 148+/-7 min till steady state, followed by 300 min lipid/heparin infusion). Responses of total ghrelin and acyl-ghrelin were measured at timed intervals throughout the clamps. Des-acyl-ghrelin concentrations were calculated by subtraction. Total ghrelin significantly decreased vs baseline concentrations (819+/-92 vs 564+/-58 pg/ml, p<0.001), thereby confirming previous observations. Des-acyl ghrelin closely followed total ghrelin concentrations and significantly decreased vs baseline (772+/-92 vs 517+/-56 pg/ml, p<0.001). In contrast, neither euglycemichyperinsulinemia nor euglycemic-hyperinsulinemic- hyperlipidemia suppressed acyl-ghrelin below baseline concentrations throughout the clamps (46+/-3 vs 47+/-8 pg/ml, p=0.90). In conclusion, moderate hyperinsulinemic and hyperinsulinemic- hyperlipidemic clamp conditions differentially modulated circulating total ghrelin and acylghrelin in humans. Factors other than changes in insulin and lipid concentrations are likely to contribute to the previously reported post-prandial reduction of circulating acyl-ghrelin.
Collapse
Affiliation(s)
- M O Weickert
- Department of Clinical Nutrition, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
| | | | | | | | | | | | | | | |
Collapse
|
41
|
Otto C, Otto B, Frost RJA, Vogeser M, Pfeiffer AFH, Spranger J, Parhofer KG. Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia. Acta Diabetol 2007; 44:65-8. [PMID: 17530469 DOI: 10.1007/s00592-007-0244-8] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/31/2006] [Accepted: 02/23/2007] [Indexed: 01/27/2023]
Abstract
Lipid-lowering therapy is associated with reduced cardiovascular risk. The aim of the present study was to investigate whether lipid-lowering therapy might be associated with changes in the concentrations of metabolically important hormone concentrations. We performed a randomised cross-over open-label trial with atorvastatin (10 mg/day) and fenofibrate (200 mg/day), each for 6 weeks separated by a 6-week washout period in 13 patients (5 men, 8 women, age 60.0+/-6.8 years, body mass index 30.0+/-3.0 kg/m2) with type 2 diabetes mellitus and mixed hyperlipoproteinaemia. Plasma ghrelin (RIA, Phoenix Pharmaceuticals, Mountain View, CA, USA), adiponectin (ELISA, Biovendor, Heidelberg, Germany) as well as resistin (ELISA, Linco Research, St. Charles, MO, USA) concentrations were measured before and after atorvastatin as well as before and after fenofibrate. Ghrelin (462+/-84 pg/ml before vs. 464+/-102 pg/ml after atorvastatin, n.s.; 454+/-85 pg/ml before vs. 529+/-266 pg/ml after fenofibrate, n.s.), resistin (24.4+/-7.4 pg/ml before vs. 23.7+/-9.1 pg/ml after atorvastatin, n.s.; 23.4+/-8.2 pg/ml before vs. 19.9+/-5.5 pg/ml after fenofibrate, n.s.), adiponectin (10.89+/-5.33 pg/ml before vs. 12.41+/-5.75 pg/ml after atorvastatin, n.s.; 12.58+/-9.87 pg/ml before vs. 10.27+/-5.23 pg/ml after fenofibrate, n.s.) and insulin levels did not change significantly during lipid-lowering therapy. In patients with type 2 diabetes and mixed hyperlipoproteinaemia, short-term atorvastatin as well as fenofibrate therapy had no significant effects on adiponectin, ghrelin or resistin levels.
Collapse
Affiliation(s)
- C Otto
- Medical Department 2 - Grosshadern, University Hospital Munich, Marchioninistrasse 15, D-81377, Munich, Germany
| | | | | | | | | | | | | |
Collapse
|
42
|
Otto B, Cuntz U, Otto C, Heldwein W, Riepl RL, Tschöp MH. Peptide YY release in anorectic patients after liquid meal. Appetite 2007; 48:301-4. [PMID: 17157959 DOI: 10.1016/j.appet.2006.06.008] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2005] [Revised: 06/27/2006] [Accepted: 06/28/2006] [Indexed: 12/25/2022]
Abstract
Fasting and postprandial levels of human peptide YY (PYY) were recently found to be lower in obesity. To investigate whether PYY levels are correspondingly high in patients with anorexia nervosa, PYY concentrations were analyzed under basal conditions and in response to a liquid meal. We investigated PYY plasma levels in 16 female anorectic (BMI 15.2+/-0.3 kg/m2) and seven lean subjects (BMI 21.3+/-0.6 kg/m2) before and after ingestion of a liquid meal (250 kcal; 15% protein, 55% carbohydrates, and 30% fat). PYY levels were analyzed using PYY ELISA (DSL, USA). Values are given as mean+/-SEM. Basal PYY levels in anorectic patients (89.0+/-14.4 pg/mL) were not significantly different from lean subjects (64.1+/-12.1 pg/mL). Postprandial PYY levels in healthy volunteers increased significantly after 20 and 60 min (80.4+/-12.7 and 96.0+/-19.9 pg/mL, respectively). In anorectic women PYY was increased at 20 min (137.9+/-19.5 pg/mL) and at 60 min (151.3+/-19.2 pg/mL). No difference was found between both groups. We conclude that basal and postprandial PYY levels in normal weight women are not different from anorectic patients. We could not confirm the recently published blunted postprandial PYY response in anorexia, a finding that merits further study.
Collapse
Affiliation(s)
- B Otto
- Medical Department, University Hospital-Innenstadt, Ziemssenstr. 1, D-80336 Munich, Germany.
| | | | | | | | | | | |
Collapse
|
43
|
Fransolet AC, Born JD, Misson JP, Dresse MF, Forget P, Rausin L, Otto B, Weerts E, Rutten I, Closon MT, Bolle S, Lebrethon MC, Mouchamps M, Hoyoux C. [Management of medulloblastoma in children: the experience of a single institution in Liege from 1991 to 2005]. Rev Med Liege 2007; 62:200-4. [PMID: 17566389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/15/2023]
Abstract
We present the experience of the Citadelle Hospital (Liege, B) in the diagnosis, treatment and follow-up of medulloblastoma in children. A retrospective study of 10 cases of medulloblastoma was performed. Five years after diagnosis, the event-free survival was 77%.
Collapse
|
44
|
Roemmler J, Otto B, Steffin B, Bidlingmaier M, Schopohl J. Ghrelin and leptin serum levels during an oral glucose tolerance test in active and inactive acromegalic patients. Exp Clin Endocrinol Diabetes 2007. [DOI: 10.1055/s-2007-972501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
45
|
Rudovich N, Gögebakan ÖG, Otto B, Mohlig M, Spranger J, Weickert M, Pfeiffer AFH. The influence of gastric inhibitory polypeptide on ghrelin secretion in different metabolic conditions. Exp Clin Endocrinol Diabetes 2007. [DOI: 10.1055/s-2007-972222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
46
|
Rapps N, Enck P, Martens U, Sammet I, Teufel M, Otto B, Zipfel S. Digestive und prädigestive Funktionen bei Patienten mit Essstörungen. Z Gastroenterol 2007; 45:273-80. [PMID: 17357959 DOI: 10.1055/s-2006-927383] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
Patients with eating disorders (anorexia nervosa, AN; bulimia nervosa, BN) frequently exhibit gastrointestinal symptoms and altered gastrointestinal functions, especially delayed gastric emptying. These symptoms are regarded as secondary to the disordered eating behaviour, vomiting or laxative misuse. They often improve during successful therapy. There are, however, studies showing that in addition predigestive functions (smell, taste, cephalic phase of digestion) and the hormonal regulation of digestion may be changed in eating disorders. This underlines the possibility that, in a subpopulation of patients with AN and BN, the disturbed digestive and predigestive functions may be involved in the pathogenesis of the eating disorders. The current literature is analysed and summarised in this context.
Collapse
Affiliation(s)
- N Rapps
- Medizinische Universitätsklinik, Abteilung für Psychosomatische Medizin und Psychotherapie, Universitätsklinikum Tübingen, Osianderstrasse 5, 72076 Tübingen
| | | | | | | | | | | | | |
Collapse
|
47
|
Pfluger PT, Kampe J, Castaneda TR, Vahl T, D'Alessio DA, Kruthaupt T, Benoit SC, Cuntz U, Rochlitz HJ, Moehlig M, Pfeiffer AFH, Koebnick C, Weickert MO, Otto B, Spranger J, Tschöp MH. Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36. J Clin Endocrinol Metab 2007; 92:583-8. [PMID: 17119001 DOI: 10.1210/jc.2006-1425] [Citation(s) in RCA: 147] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
BACKGROUND Recent findings suggest that low plasma peptide YY (PYY) levels may contribute to diet-induced human obesity and justify PYY replacement therapy. Although the pharmacological value of PYY is controversial, further study of the secretion of the precursor PYY(1-36) and the pharmacologically active PYY(3-36) is indicated to determine the potential role in energy balance regulation. AIM Our objective was to determine the effects of acute and chronic changes in human body weight on circulating levels of the putative satiety hormone peptide YY. DESIGN Total plasma PYY levels (PYY(1-36) + PYY(3-36)) were measured in 66 lean, 18 anorectic, 63 obese, and 16 morbidly obese humans. In addition, total PYY was measured in 17 of the obese patients after weight loss and in the 18 anorectic patients after weight gain. Fasting PYY(3-36) levels were measured in 17 lean and 15 obese individuals. RESULTS Fasting total plasma PYY levels were highest in patients with anorexia nervosa (80.9 +/- 12.9 pg/ml, P < 0.05) compared with lean (52.4 +/- 4.6 pg/ml), obese (43.9 +/- 3.8 pg/ml), or morbidly obese (45.6 +/- 11.2 pg/ml) subjects. In obese patients, weight loss of 5.4% was associated with a 30% decrease in fasting total PYY plasma levels. In anorectic patients, weight gain had no effect on fasting PYY. PYY(3-36) levels did not differ between lean (96.2 +/- 8.6 pg/ml) and obese (91.5 +/- 6.9 pg/ml) subjects. CONCLUSION Our findings do not support a role for abnormal circulating PYY in human obesity. We conclude that circulating PYY levels in humans are significantly elevated in anorexia nervosa and, given the controversially discussed anorectic effect of PYY, could theoretically contribute to that syndrome.
Collapse
Affiliation(s)
- P T Pfluger
- Department of Psychiatry, University of Cincinnati, Office E-217, Genome Research Institute, 2170 East Galbraith Road, Cincinnati, Ohio 45237, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Weickert MO, von Löffelholz C, Arafat AM, Schöfl C, Otto B, Möhlig M, Pfeiffer AFH. Hyperinsulinämische und hyperinsulinämisch-hyperlipidämische Bedingungen supprimieren Gesamt-Ghrelin, aber nicht orexigen aktives Acyl-Ghrelin bei gesunden normalgewichtigen Personen. DIABETOL STOFFWECHS 2007. [DOI: 10.1055/s-2007-982383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
49
|
Klose J, Otto C, Enck P, Klosterhalfen S, Heldwein W, Otto B. Does ghrelin increase during nausea? Z Gastroenterol 2006. [DOI: 10.1055/s-2006-955492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
50
|
Otto B, Brennan IM, Feltrin KL, Meyer JH, Heldwein W, Horowitz M, Feinle-Bisset C. Intravenous administration of cholecystokinin (CCK) suppresses ghrelin and stimulates peptide YY (PYY) release in healthy men. Z Gastroenterol 2006. [DOI: 10.1055/s-2006-955528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|